ニュース

Modern Retina4 日
Ocugen announces new SAB members and leadership changes
Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...
Modern Retina16 日
FDA agrees to expand Atsena's gene therapy trial for XLRS treatment
Atsena Therapeutics expands its ATSN-201 trial for X-linked retinoschisis, a step toward the first gene therapy treatment.
Modern Retina24年
Phase 3 PHOENIX trial for oral GA treatment completes enrollment
Belite Bio completes enrollment in the pivotal PHOENIX trial, advancing tinlarebant's potential to treat geographic atrophy.
modernretina9 日
FDA grants fast track designation to SAR446597
Sanofi's SAR446597 receives FDA fast track designation, offering a promising one-time gene therapy for geographic atrophy and reducing treatment frequency. The US Food and Drug Administration (FDA) ...